Loading...
An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins
Insulin analog patent expiry is likely to mean that, increasingly, copies of original biopharmaceutical products will be submitted for authorization. Experience with biosimilars in other therapeutic areas suggests that careful regulation and caution are needed. Published guidelines of regulatory aut...
Na minha lista:
| Udgivet i: | Diabetes Technol Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc.
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4504437/ https://ncbi.nlm.nih.gov/pubmed/25789689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2014.0362 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|